Gender differences in fasting and postprandial metabolic traits predictive of subclinical atherosclerosis in an asymptomatic Chinese population

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Xinpeng Loh
  • Lijuan Sun
  • John Carson Allen
  • Hui Jen Goh
  • Siew Ching Kong
  • Weiting Huang
  • Cherlyn Ding
  • Nabil Bosco
  • Leonie Egli
  • Lucas Actis-Goretta
  • Magkos, Faidon
  • Fabrizio Arigoni
  • Khung Keong Yeo
  • Melvin Khee-Shing Leow

The prediction utility of Framingham Risk Score in populations with low conventional cardiovascular risk burden is limited, particularly among women. Gender-specific markers to predict cardiovascular risk in overtly healthy people are lacking. In this study we hypothesize that postprandial responses triggered by a high-calorie meal test differ by gender in their ability to triage asymptomatic subjects into those with and without subclinical atherosclerosis. A total of 101 healthy Chinese subjects (46 females, 55 males) at low risk of coronary heart disease completed the study. Subjects underwent cardiovascular imaging and postprandial blood phenotyping after consuming a standardized macronutrient meal. Prediction models were developed using logistic regression and subsequently subjected to cross-validation to obtain a de-optimized receiver operating characteristic (ROC) curve. Distinctive gender differences in postprandial trajectories of glucose, lipids and inflammatory markers were observed. We used gender-specific association with different combinations of postprandial predictors to develop 2 models for predicting risk of subclinical atherosclerosis in males (ROC AUC = 0.7867, 95% CI 0.6567, 0.9166) and females (ROC AUC = 0.9161, 95% CI 0.8340, 0.9982) respectively. We report novel postprandial models for predicting subclinical atherosclerosis in apparently healthy Asian subjects using a gender-specific approach, complementing the conventional Framingham Risk Score.

Clinical Trial Registration: The trial was registered at clinicaltrials.gov as NCT03531879.

OriginalsprogEngelsk
Artikelnummer16890
TidsskriftScientific Reports
Vol/bind12
Antal sider14
ISSN2045-2322
DOI
StatusUdgivet - 2022

Bibliografisk note

CURIS 2022 NEXS 254
© 2022. The Author(s).

ID: 322947042